Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer (Q33845220)

29 July 2017

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

John L Gore

2

0 references

Mark S Litwin

1

object named as

Mark S Litwin

1 reference

29 July 2017

Lorna Kwan

3

1 reference

29 July 2017

Judson M Brandeis

4

1 reference

29 July 2017

Steve P Lee

5

1 reference

29 July 2017

H Rodney Withers

6

1 reference

29 July 2017

Robert E Reiter

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

29 July 2017

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

29 July 2017

109

1 reference

29 July 2017

2239-2247

1 reference

29 July 2017

11

1 reference

29 July 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Time course and predictors of symptoms after primary prostate cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Quality of life after radical prostatectomy or watchful waiting.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Sex or survival: trade-offs between quality and quantity of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Variation in Continence and Potency by Definition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Urinary symptom flare following I-125 prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Rectal function following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22676

7 January 2021

Identifiers

DOI

10.1002/CNCR.22676

1 reference

29 July 2017

1 reference